Kiniksa Pharmaceuticals (KNSA) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Kiniksa Pharmaceuticals (KNSA) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 19, 2024 (15:12)

Sector: Healthcare

The share price of Kiniksa Pharmaceuticals, Ltd. (KNSA) now

Latest session on the 18th of July for
Kiniksa Pharmaceuticals, Ltd. is negative
Trading Volume: 304715
Open: 21.36 /  High: 21.465 /  Low: 20.94
What analysts predict: $30.5
52-week High/Low: $22.65 / $14.12

50/200 Day Moving Average: $19.4 / $18.43

This figure corresponds to the Average Price over the previous 50/200 days. For Kiniksa Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Kiniksa Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Kiniksa Pharmaceuticals, Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kiniksa Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Kiniksa Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Kiniksa Pharmaceuticals stock? When should I record a loss on Kiniksa Pharmaceuticals stock? What are analysts' forecasts for Kiniksa Pharmaceuticals stock? What is the future of Kiniksa Pharmaceuticals stock? We forecast Kiniksa Pharmaceuticals stock performance using neural networks based on historical data on Kiniksa Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kiniksa Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kiniksa Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Kiniksa Pharmaceuticals stock

The chart below shows the historical price of Kiniksa Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kiniksa Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Kiniksa Pharmaceuticals, Ltd., a clinical stage biopharmaceutical company, specializes in the discovery, acquisition, development and commercialization of therapeutic drugs for severely ill patients with significant unmet medical needs around the world.

Kiniksa Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 21 22.45 21.94 23.11 5.36
Jul 22 22.86 22.64 23.35 3.15
Jul 23 22.88 22.60 23.20 2.63
Jul 24 22.33 21.64 22.55 4.21
Jul 25 22.36 21.95 22.92 4.44
Jul 26 22.81 22.44 23.07 2.81
Jul 27 22.80 22.53 23.21 3.00
Jul 28 22.41 22.03 22.64 2.81
Jul 29 22.27 22.04 22.78 3.35
Jul 30 21.57 21.00 21.88 4.15
Jul 31 21.92 21.41 22.41 4.67
Aug 01 21.68 21.12 22.32 5.67
Aug 02 21.34 21.12 21.57 2.10
Aug 03 21.22 20.78 21.48 3.35
Aug 04 21.05 20.58 21.28 3.40
Aug 05 21.85 21.35 22.27 4.30
Aug 06 21.50 20.95 21.69 3.53
Aug 07 21.59 21.29 22.00 3.33
Aug 08 21.68 21.06 22.04 4.65
Aug 09 21.99 21.56 22.34 3.63
Aug 10 21.56 20.92 22.19 6.06
Aug 11 21.06 20.56 21.29 3.56
Aug 12 21.25 20.95 21.70 3.61
Aug 13 21.60 21.19 22.01 3.83
Aug 14 21.72 21.31 22.26 4.44
Aug 15 22.16 21.84 22.79 4.34
Aug 16 22.13 21.86 22.31 2.02
Aug 17 22.21 21.91 22.41 2.31
Aug 18 22.16 21.87 22.64 3.53
Aug 19 22.56 22.26 23.10 3.81

Kiniksa Pharmaceuticals Daily Price Targets


Kiniksa Pharmaceuticals Stock Forecast 07-21-2024.

Forecast target price for 07-21-2024: $22.45.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 5.089%.
Pessimistic target level: 21.94
Optimistic target level: 23.11

Kiniksa Pharmaceuticals Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $22.86.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 3.054%.
Pessimistic target level: 22.64
Optimistic target level: 23.35

Kiniksa Pharmaceuticals Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $22.88.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 2.564%.
Pessimistic target level: 22.60
Optimistic target level: 23.20

Kiniksa Pharmaceuticals Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $22.33.
Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.040%.
Pessimistic target level: 21.64
Optimistic target level: 22.55

Kiniksa Pharmaceuticals Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $22.36.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.253%.
Pessimistic target level: 21.95
Optimistic target level: 22.92

Kiniksa Pharmaceuticals Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $22.81.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 2.729%.
Pessimistic target level: 22.44
Optimistic target level: 23.07

KNSA (KNSA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 21.64 20.50 22.58 9.20
Sep. 20.76 19.64 21.53 8.79
Oct. 19.79 18.03 21.31 15.38
Nov. 19.17 18.00 19.81 9.17
Dec. 19.26 18.18 20.44 11.08

Kiniksa Pharmaceuticals forecast for this year


Kiniksa Pharmaceuticals Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $21.6412. Pessimistic: $20.50. Optimistic: $22.58


Kiniksa Pharmaceuticals Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $20.7583. Pessimistic: $19.64. Optimistic: $21.53


Kiniksa Pharmaceuticals Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $19.7868. Pessimistic: $18.03. Optimistic: $21.31


Kiniksa Pharmaceuticals Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $19.1694. Pessimistic: $18.00. Optimistic: $19.81


Kiniksa Pharmaceuticals Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $19.2614. Pessimistic: $18.18. Optimistic: $20.44



Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 19.79 18.70 20.51 8.80
Feb 19.86 18.20 21.65 15.96
Mar 20.60 19.99 22.16 9.82
Apr 20.41 18.89 21.61 12.58
May 18.76 17.98 19.87 9.52
Jun 18.25 17.02 19.50 12.69
Jul 16.17 15.24 17.08 10.79
Aug 17.76 16.05 18.76 14.43
Sep 19.42 18.21 19.91 8.54
Oct 20.21 18.88 21.45 11.99
Nov 19.39 17.99 19.88 9.48
Dec 19.09 17.71 20.83 14.96

Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 18.38 16.70 19.30 13.48
Feb 17.47 16.44 18.67 11.91
Mar 17.87 16.93 18.41 8.04
Apr 17.74 17.23 19.08 9.71
May 18.63 17.23 20.07 14.15
Jun 16.47 15.85 17.85 11.18
Jul 16.98 16.51 17.69 6.68
Aug 18.32 17.75 18.94 6.27
Sep 17.75 16.26 19.07 14.74
Oct 19.12 17.65 20.17 12.51
Nov 19.00 17.77 19.94 10.87
Dec 19.73 18.36 21.03 12.72

Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 19.71 17.84 20.82 14.31
Feb 18.10 17.45 18.60 6.19
Mar 18.69 18.21 20.19 9.77
Apr 19.69 19.20 21.30 9.87
May 20.05 18.77 21.97 14.56
Jun 20.19 19.01 21.50 11.61
Jul 21.48 20.24 22.56 10.28
Aug 23.10 22.35 24.88 10.14
Sep 25.76 25.05 26.75 6.36
Oct 27.62 25.76 28.74 10.38
Nov 26.82 25.12 29.36 14.47
Dec 23.60 22.41 25.47 12.01

Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 23.41 22.84 25.62 10.85
Feb 23.63 21.45 25.36 15.43
Mar 24.40 22.90 25.54 10.32
Apr 26.33 25.29 27.28 7.30
May 24.87 23.14 26.25 11.83
Jun 27.83 25.66 30.43 15.69
Jul 27.13 25.86 29.57 12.55
Aug 28.79 26.40 31.14 15.20
Sep 27.13 25.21 28.92 12.83
Oct 28.17 26.41 30.07 12.14
Nov 28.65 26.27 29.44 10.74
Dec 29.30 28.17 31.41 10.30

Kiniksa Pharmaceuticals information and performance

Kiniksa Pharmaceuticals Address

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BM

Market Capitalization: 1 521 872 000 $

Market capitalization of the Kiniksa Pharmaceuticals, Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KNSA shares in the company outstanding by the market price of one share.

EBITDA: -28 331 000 $

EBITDA of Kiniksa Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: 164.69

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.13

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 5.5
Quarterly Revenue Growth YOY: 0.652
Trailing PE: 164.69

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.799

Enterprise Value (EV) /Revenue

EV To EBITDA: -44.93

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 40447500

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.